Which Hedge Funds Own MLTX — Moonlake Immunotherapeutics Co

17 of the hedge funds we track hold MLTX, worth $312.3M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 8 added, 8 trimmed.

13 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at MLTX · All tracked funds